Scientific article
OA Policy
English

Appropriate endpoints for evaluation of new antibiotic therapies for severe infections: a perspective from COMBACTE's STAT-Net

Published in

Intensive Care Medicine, vol. 43, no. 7, p. 1002-1012

Publication date

2017

Abstract

In this era of rising antimicrobial resistance, slowly refilling antibiotic development pipelines, and an aging population, we need to ensure that randomized clinical trials (RCTs) determine the added benefit of new antibiotic agents effectively and in a valid way, especially for severely ill patients. Unfortunately, universally accepted endpoints for the evaluation of new drugs in severe infections are lacking.

Citation (ISO format)

TIMSIT, Jean-François et al. Appropriate endpoints for evaluation of new antibiotic therapies for severe infections: a perspective from COMBACTE’s STAT-Net. In: Intensive Care Medicine, 2017, vol. 43, n° 7, p. 1002–1012. doi: 10.1007/s00134-017-4802-4

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

0342-4642
530views
361downloads

Technical informations

Creation

20/10/2017 19:09:00

First validation

20/10/2017 19:09:00

Update

13/10/2025 19:33:02

Status update

08/10/2024 09:13:24

Last indexation

10/11/2026 13:18:34
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated